Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Vivus Inc (VVUS)

0.7867 -0.013 (-1.66%)

05-21 16:00

Open:

0.8292

Pre. Close:

0.8

High:

0.905

Low:

0.7501

Volume:

5,336,901

Market Cap:

83M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.902 - 0.907

0.907 - 0.91

Low:

0.74 - 0.745

0.745 - 0.749

Close:

0.792 - 0.801

0.801 - 0.807

Technical analysis  (as of: 2018-05-21 4:34:47 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 1.06     One year: 1.23

Support:

Support1: 0.57    Support2: 0.36

Resistance:

Resistance1: 0.90    Resistance2: 1.06

Pivot:

0.56

Moving Averages:

MA(5): 0.68     MA(20): 0.51

MA(100): 0.46     MA(250): 0.75

MACD:

MACD(12,26): 0.08     Signal(12,26,9): 0.04

%K %D:

%K(14,3): 81.67     %D(3): 81.05

RSI:

RSI(14): 74.59

52-Week:

High: 1.38  Low: 0.33  Change(%): -29.0

Average Vol(K):

3-Month: 114479  10-Days 276908

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
VVUS has closed above the upper band by 5.4%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 202.7% wider than normal. The large width of the bands suggest high volatility as compared to VVUS's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue.

Headline News

2018-05-08T22:40:58-04:00
Vivus' (VVUS) CEO John Amos on Q1 2018 Results - Earnings Call Transcript

2018-05-08T16:14:08-04:00
Vivus beats by $0.01, misses on revenue

2018-05-02T10:15:41-04:00
Vivus On The Move With Capital Restructure And Acquisition

2018-04-26T11:08:50-04:00
Pending Orexigen Sale Should Serve As Warning Sign

2018-03-24T01:55:21-04:00
Novo Nordisk Can Succeed In Weight Loss Where Orexigen, Vivus, Arena Failed

2018-03-19T13:58:12-04:00
Orexigen Files For Bankruptcy - Investors Need To Get Savvy

2018-03-13T16:22:41-04:00
Vivus beats by $0.03, misses on revenue

2018-01-05T01:36:56-05:00
Your Daily Pharma Scoop: ChemoCentryx Surges, Akebia Gets Positive News, Atara Prices Public Offering

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

106.05

Shares Float (M)

103.44

% Held by Insiders

2.50

% Held by Institutions

24.50

Shares Short (K)

4902

Shares Short Prior Month (K)

5040

Stock Financials

EPS

-0.390

EPS Est. Current Year

-0.390

EPS Est. Next Year

-0.450

EPS Est. Next Quarter

-0.130

Forward EPS

-0.570

Book Value (p.s.)

127.200

PEG Ratio

-1.11

Profit Margin

-79.80

Operating Margin

-13.40

Return on Assets (ttm)

-14.7

Return on Equity (ttm)

5135.5

Qtrly Rev. Growth

-55.9

Gross Profit (p.s.)

0.182

Sales Per Share

EBITDA (p.s.)

-0.020

Qtrly Earnings Growth

Operating Cash Flow (M)

-21.28

Levered Free Cash Flow (M)

-5.04

atoplab.com

Valuation

P/E

-2.04

P/E Growth Ratio

-0.01

P/BV

0.01

P/S

179405008.00

P/CF

-3.96

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.